Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd > Great excerpt from todays release

<< Previous

Bullboard Posts

Next >>

Comment by droz1115on Jan 06, 2014 7:22pm

138 Views

Post# 22063743

RE:RE:Great excerpt from todays release

Yes, I definitely like the management. I like to see all the buying they've been doing at bottom of the barrell prices these past 6 months. I like the news release and I would like to see more of them as well. Good to hear we're in for more drilling and possilbe expansion this year though.
The hurt we've all suffered in the junior mining sector should definitely be nearing or already at its end. Many juniors are down 80-90% since their 2011 highs and they're better companies now (like NOX). I've taken a beating in some of my holdings and I'm looking forward to seeing our market bounce back early this year! GLTA

<< Previous

Bullboard Posts

Next >>

Gold begins to flow at Endeavour's Lafigué mine in Côte d'Ivoire